Are Ribosomal Readthrough Drugs the Next Biotech Magic Bullet?

On a recent press tour of New Jersey I was introduced to PTC Therapeutics, a fascinating company that is developing ribosomal readthrough drugs for several indications. What I find so interesting about this company and their technology is that it is a sort of magic bullet. Drugs that can modulate ribosomal activity can potentially treat […]


Seeds, food and trade wars: Public opinion and policy responses in the USA and Europe

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Seeds, food and trade wars: Public opinion and policy responses in the USA and Europe
Go to paperABSTRACT: The political debate over genetically modified fo…


Biotechblog